Calcium alginate gel as a biocompatible material for endovascular arteriovenous malformation embolization: Six-month results in an animal model

Neurosurgery

Volumn 56, Issue 4, 2005, Pages 793-800

  Becker, Timothy A ^a,c   Preul, Mark C ^b   Bichard, William D ^b   Kipke, Daryl R ^a   McDougall, Cameron G ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

Biocompatible hydrogel; Calcium alginate; Cerebral arteriovenous malformation; Embolization; Endovascular occlusion; Microcatheter injection; Rete mirabile

Indexed keywords

ALGINIC ACID; CALCIUM ALGINATE; CALCIUM CHLORIDE; COPOLYMER; EXCIPIENT; GULURONIC ACID; MANNURONIC ACID; MEGLUMINE IOTALAMATE; TANTALUM; UNCLASSIFIED DRUG; WATER;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS MALFORMATION; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN BLOOD FLOW; CATHETERIZATION; COMMON CAROTID ARTERY; END TO SIDE ANASTOMOSIS; FLUOROSCOPY; HISTOLOGY; HYDROGEL; INJECTION; JUGULAR VEIN; NONHUMAN; PRIORITY JOURNAL; SWINE; TREATMENT OUTCOME;

ALGINATES; ANIMALS; ARTERIOVENOUS MALFORMATIONS; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; GLUCURONIC ACID; HEXURONIC ACIDS; SWINE;

EID: 16844377521     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000156494.94675.BB     Document Type: Article

References (34)

1. Becker TA, Kipke DR: Flow properties of liquid calcium alginate polymer when injected through medical microcatheters for endovascular embolization. J Biomed Mater Res 61:533-540, 2002.
2. Becker TA, Collins VE, Kipke DR: Endovascular occlusion of vascular defects utilizing the biocompatible and two component polymer: Calcium alginate. US Patent 6 592 566. July 15, 2003.
3. Becker TA, Kipke DR, Brandon T: Calcium alginate gel: A biocompatible and mechanically stable polymer for endovascular embolization. J Biomed Mater Res 54:76-86, 2001.
4. Becker TA, Kipke DR, Preul MC, Bichard W, McDougall CG: In vivo assessment of calcium alginate gel for endovascular embolization of a swine rete model. Neurosurgery 51:453-459, 2002.
5. Chaloupka JC, Vinuela F, Vinters HV, Robert J: Technical feasibility and histopa thologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol 15:1107-1115, 1994.
6. Charoo NA, Kohli K, Ali A, Anwer A: Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: In vitro and in vivo studies. Drug Dev Ind Pharm 29:215-221, 2003.
7. Duffner F, Ritz R, Bornemann A, Freudenstein D, Wiendl H, Siekmann R: Combined therapy of cerebral arteriovenous malformations: Histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol 21:13-17, 2002.
8. Gruber A, Mazal PR, Bavinski G, Killer M, Budka H, Richling B: Repermeation of partially embolized cerebral arteriovenous malformations: A clinical, radiologic and histologic study. AJNR Am J Neuroradiol 17: 1323-1331, 1996.
9. Hashimoto T, Suzuki Y, Tanihara M, Kakimaru Y, Suzuki K: Development of alginate wound dressings linked with hybrid peptides derived from laminin and elastin. Biomaterials 25:1407-1414, 2004.
10. Klisch J, Requejo F, Yin L, Eissner B, Schumacher M: The two-in-one model: A new variation of the arteriovenous malformation model in swine. Neuroradiology 45:393-397, 2001.
11. Lanza RP, Kuhtreiber WM, Ecker D, Staruk JE, Chick WL: Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 59:1377-1384, 1995.
12. Lim, EB, Kennedy RA: Studies on diffusion in alginate gels: Part II-Effect of acid and subsequent re-exposure to calcium on the diffusion of caffeine and theophylline in alginate gel films. Pharm Dev Technol 2:285-292, 1997.
13. Limova M: Evaluation of two calcium alginate dressings in the management of venous ulcers. Ostomy Wound Manage 49:26-33, 2003.
14. Massoud TF, Ji C, Viñuela E, Guglielmi G, Robert J, Duckwiler GR, Gobin YP: An experimental arteriovenous malformation model in swine: Anatomic basis and construction technique. AJNR Am J Neuroradiol 15:1537-1545, 1994.
15. Massoud TF, Ji C, Viñuela F, Turjman F, Guglielmi G, Duckwiler GR, Gobin YP: Laboratory simulations and training in endovascular embolotherapy with a swine arteriovenous malformation model. AJNR Am J Neuroradiol 17:271-279, 1996.
16. Massoud TF, Vinters HV, Chao KH, Viñuela F, Jahan R: Histopathological characteristics of a chronic arteriovenous malformation in a swine model: Preliminary study. AJNR Am J Neuroradiol 21:1268-1276, 2000.
17. Morris D, Goldschlager N: Calcium infusion for reversal of adverse effects of intravenous verapamil. JAMA 249:3212-3213, 1983.
18. Murayama Y, Massoud TF, Vinuela F: Transvenous hemodynamic assessment of experimental arteriovenous malformations: Doppler guidewire monitoring of embolotherapy in a swine model. Stroke 27:1365-1372, 1996.
19. Murayama Y, Massoud TF, Viñuela F: Hemodynamic changes in arterial feeders and draining veins during embolotherapy of arteriovenous malformations: An experimental study in a swine model. Neurosurgery 43:96-106, 1998.
20. Murayama Y, Viñuela F, Ulhoe A, Akiba Y, Duckwiler GR, Gobin YP, Vinters HV, Greff RJ: Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: Preliminary histopathological studies in swine rete mirabile. Neurosurgery 43:1164-1175, 1998.
21. Raymond J, Metcalfe A, Desfaits AC, Ribourtout E, Salazkin I, Gilmartin K, Embry G, Boock RJ: Alginate for endovascular treatment of aneurysms and local growth factor delivery. AJNR Am J Neuroradiol 24:1214-1221, 2003.
22. Remunan-Lopez C, Portero A, Vila-Jato JL, Alonso MJ: Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release 55:143-152, 1998.
23. Rudd KD, Morrow RM, Strunk RR: Accurate alginate impressions. J Prosthet Dent 22:294-300, 1969.
24. Deleted in proof.
25. Soga Y, Preul MC, Furuse M. Becker T, McDougall CG: Calcium alginate provides a high degree of embolization in aneurysm models: a specific comparison to coil packing. Neurosurgery 55:1401-1409, 2004.
26. Stevens MM, Qanadilo HF, Langer R, Shastri VP: A rapid curing alginate gel system: Utility in periosteum-derived cartilage tissue engineering. Biomaterials 25:887-894, 2004.
27. Storer RA: Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue-engineered Medical Products Application: F2064-00. 2003 ASTM Annual Book of ASTM Standards. West Conshohocken, American Society for Testing and Materials, 2003, vol 13.01.
28. Storer RA: Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Cels: F2315-03. 2003 ASTM. Annual Book of ASTM Standards. West Conshohocken, American Society for Testing and Materials, 2003, vol 13.01.
29. Thomas S: Alginate dressings in surgery and wound management: Part 1. J Wound Care 9:56-60, 2000.
30. Thomas S: Alginate dressings in surgery and wound management: Part 2. J Wound Care 9:115-119, 2000.
31. Thomas S: Alginate dressings in surgery and wound management: Part 3. J Wound Care 9:163-166, 2000.
32. 2 system for membrane coat application. J Pharm Sci 90:1134-1142, 2001.
33. Weiner D: Calcium channel blockers. Med Clin North Am 72:83-115, 1988.
34. Yan XL, Khor E, Lim LY: Chitosan-alginate films prepared with chitosans of different molecular weights. J Biomed Mater Res 58:358-365, 2001.